Skip to content

McKesson names Tyler president and COO

McKesson Corp. today named Brian Tyler president and chief operating officer, effective August 2. In his new role, Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee. McKesson also announced the departure of  U.S.

Table of Contents

SAN FRANCISCO — McKesson Corp. today named Brian Tyler president and chief operating officer, effective August 2. In his new role, Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.

McKesson also announced the departure of  U.S. Pharmaceutical and Specialty Solutions president Nick Loporcaro, effective August 10, to pursue other opportunities,. Tyler will fill in for Loporcaro until the company names a permanent replacement.

“Brian is ideally suited to lead McKesson’s global operations based on his deep industry knowledge, outstanding track record as a business leader, and his commitment to operational excellence and customer success,” said Hammergren. “His broad experience as the president of multiple McKesson businesses provides him with the ideal background and perspective to help lead McKesson’s strategic initiative and drive long-term growth.”

Brian Tyler

Tyler had previously been chairman of the management board of McKesson Europe, and also served as president of the company’s North American Pharmaceutical Distribution and Services unit, and the U.S. Pharmaceutical, Medical-Surgical, and Specialty Health divisions, as well as executive vice president of corporate strategy and business development. Tyler’s direct reports will include the presidents of U.S. Pharmaceutical and Specialty Health, Medical-Surgical, McKesson Prescription Technology Solutions (MRxTS), Transformation Initiatives, the CEO of McKesson Canada and the chairman of the management board of McKesson Europe.

“McKesson has outstanding products, services and solutions, and world class talent,” said Tyler. “With these assets, the company is uniquely positioned to drive innovation across the health care supply chain that will improve value for our business partners and enable better, more cost-effective patient care. I look forward to working with our customers, manufacturing partners and McKesson’s more than 78,000 associates to deliver on that potential and accelerate McKesson’s growth.”

Tyler earned an M.A. and Ph.D.  from the University of Chicago Department of Economics, where he studied under a grant from the National Science Foundation, after earning a B.A. in economics with high honors from University of California Santa Cruz in 1989.

Comments

Latest